COVID-19: green light for Pfizer's bivalent booster vaccine for children

COVID-19: green light for Pfizer's bivalent booster vaccine for children< /p> UPDATE DAY

Health Canada authorized the Pfizer-BioNTech bivalent vaccine suitable for BA.4/BA.5 subvariants as a booster dose for children 5 to 11 years old on Friday. < /p>

“This is the first bivalent COVID-19 vaccine directed against the original strain of the coronavirus that causes COVID-19 as well as the BA.4/BA.5 subvariants d 'Omicron whose use as a booster dose is authorized for this age group,' explained the ministry in a press release.

According to the latest data from the National Institute of Public Health of Quebec ( INSPQ), the subvariants targeted by the new vaccine represented just over 40% of the cases resulting from random sequencing between November 20 and 26 in Quebec.

Another 40% of the cases detected are associated with the BQ.1.1 sub-variant, which has experienced meteoric growth since October.

The Ministers of Health of Quebec and Canada have continued to insist on the importance of get vaccinated this fall, when infections of all kinds fill hospitals, especially pediatric hospitals.

To ease the burden on health systems, they suggest taking two vaccines at the same time times, namely those against COVID-19 and the seasonal flu, which made a strong comeback this year.

There is no vaccine against respiratory syncytial virus (RSV), the third infection that causes headaches for female healthcare workers.